PMID- 32957125 OWN - NLM STAT- MEDLINE DCOM- 20201109 LR - 20211001 IS - 1833-3516 (Print) IS - 2209-1491 (Electronic) IS - 1833-3516 (Linking) VI - 50 IP - 3 DP - 2020 Sep 30 TI - Assessment of insulin sensitivity during hyperbaric oxygen treatment. PG - 238-243 LID - 10.28920/dhm50.3.238-243 [doi] AB - INTRODUCTION: Previous studies using a hyperinsulinaemic, euglycaemic glucose clamp have demonstrated an increase in peripheral insulin sensitivity in men with and without Type-2 diabetes mellitus on the third and thirtieth hyperbaric oxygen treatment (HBOT) session. In two studies using different techniques for assessment of insulin sensitivity, we investigated the onset and duration of this insulin-sensitising effect of HBOT. METHODS: Men who were obese or overweight but without diabetes were recruited. One study performed a hyperinsulinaemic euglycaemic glucose clamp (80 mU.m(-2).min(-1)) at baseline and during the first HBOT exposure (n = 9) at a pressure of 203 kPa. Data were analysed by paired t-test. The other study assessed insulin sensitivity by a frequently sampled intravenous glucose tolerance test (FSIGT) at three time points: baseline, during the third HBOT and 24-hours post-HBOT (n = 9). Results were analysed by repeated-measures ANOVA. RESULTS: There was a significant 23% increase in insulin sensitivity by clamp measured during the first HBOT exposure. The FSIGT showed no significant changes in insulin sensitivity. CONCLUSIONS: The hyperinsulinaemic, euglycaemic glucose clamp demonstrated a significant increase in peripheral insulin sensitivity during a single, 2-hour HBOT session in a group of men who were obese or overweight but without diabetes. As an alternate technique for assessing insulin sensitivity during HBOT, the FSIGT failed to show any changes during the third HBOT and 24-hours later, however modification of the study protocol should be considered. CI - Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms. FAU - Wilkinson, David AU - Wilkinson D AD - Hyperbaric Medicine Unit, Royal Adelaide Hospital, Adelaide, Australia. AD - Adelaide Medical School, The University of Adelaide, Adelaide, Australia. AD - Corresponding author: Dr David Wilkinson, Hyperbaric Medicine Unit, Royal Adelaide Hospital, Port Road, Adelaide, SA 5000, Australia, david.wilkinson@sa.gov.au. FAU - Szekely, Suzy AU - Szekely S AD - Hyperbaric Medicine Unit, Royal Adelaide Hospital, Adelaide, Australia. FAU - Gue, Brian AU - Gue B AD - Adelaide Medical School, The University of Adelaide, Adelaide, Australia. FAU - Tam, Charmaine S AU - Tam CS AD - Centre for Translational Data Science and Northern Clinical School, Sydney, Australia. FAU - Chapman, Ian AU - Chapman I AD - Adelaide Medical School, The University of Adelaide, Adelaide, Australia. FAU - Heilbronn, Leonie K AU - Heilbronn LK AD - Adelaide Medical School, The University of Adelaide, Adelaide, Australia. LA - eng PT - Journal Article PL - Australia TA - Diving Hyperb Med JT - Diving and hyperbaric medicine JID - 101282742 RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - S88TT14065 (Oxygen) SB - IM MH - Blood Glucose MH - Glucose Clamp Technique MH - Humans MH - *Hyperbaric Oxygenation MH - Insulin MH - *Insulin Resistance MH - Male MH - Oxygen PMC - PMC7819732 OTO - NOTNLM OT - Endocrinology OT - Hyperbaric research OT - Metabolism OT - Obesity OT - Physiology COIS- Conflicts of interest and funding The authors have no conflicts to declare. Grants were provided by the Royal Adelaide Hospital Research Committee and Australasian Diving and Hyperbaric Medicine Research Trust. EDAT- 2020/09/22 06:00 MHDA- 2020/11/11 06:00 PMCR- 2021/09/30 CRDT- 2020/09/21 20:22 PHST- 2020/01/07 00:00 [received] PHST- 2020/03/18 00:00 [accepted] PHST- 2020/09/21 20:22 [entrez] PHST- 2020/09/22 06:00 [pubmed] PHST- 2020/11/11 06:00 [medline] PHST- 2021/09/30 00:00 [pmc-release] AID - 10.28920/dhm50.3.238-243 [doi] PST - ppublish SO - Diving Hyperb Med. 2020 Sep 30;50(3):238-243. doi: 10.28920/dhm50.3.238-243.